Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJun 16, 2017 12:00 pm

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at the 2017 Marcum Microcap Conference

Tonix Pharmaceuticals (NASDAQ: TNXP) is developing innovative pharmaceutical products to address major public health challenges. In addition to TNX-102 SL for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, as a potential smallpox-preventing vaccine. Company executives have a track record of success in drug development, regulatory approvals, and product launch activities. For more information, visit the company's website at www.tonixpharma.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides…

Continue Reading

FridayJun 16, 2017 11:30 am

Yield10 Bioscience, Inc. (NASDAQ: YTEN) Starts Presentation at the 2017 Marcum Microcap Conference

Yield10 Bioscience (NASDAQ: YTEN) is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean, and corn. Yield10 is based in Woburn, MA. For more information about the company, please visit www.yield10bio.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

Continue Reading

FridayJun 16, 2017 11:00 am

Pressure Biosciences, Inc. (PBIO) Starts Presentation at the 2017 Marcum Microcap Conference

Pressure Biosciences (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Over 250 PCT systems are installed worldwide and over 100 publications cite the advantages of the PCT platform over competitive methods. For more information, visit the company's website at…

Continue Reading

FridayJun 16, 2017 11:00 am

Eco Building Products, Inc. (ECOB) Starts Presentation at the 2017 Marcum Microcap Conference

Eco Building Products (OTC: ECOB) is a manufacturer of proprietary, environmentally conscientious chemistry utilizing patent pending ECOB WoodSurfaceFilm™ and FRC™ technology (Fire Retardant Coating).  Eco’s products protect against fire, mold/mycotoxins, fungal-decay, wood ingesting insects and termites.  Eco is headquartered in San Diego, CA and goes to market through licensed affiliates nationwide. For more information, visit the company's website at www.ecob.net About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full array of social communication solutions. As a multifaceted financial news…

Continue Reading

FridayJun 16, 2017 10:30 am

InspireMD, Inc. (NYSE: NSPR) Starts Presentation at the 2017 Marcum Microcap Conference

InspireMD (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes. Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures. For more information, visit the company's website at inspiremd.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service…

Continue Reading

FridayJun 16, 2017 10:00 am

Orgenesis, Inc. (ORGS) Starts Presentation at the 2017 Marcum Microcap Conference

Orgenesis (OTC: ORGS) is a biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. The company's MaSTherCell subsidiary is able to deliver optimized process industrialization capacities to cell therapy companies. MaSTherCell's customers include many of the world's leading pharmaceutical and biotech companies. Orgenesis is a pioneer in the process of trans-differentiation (cell reprograming), whereby an adult cell is converted into another type of cell. Orgenesis has successfully reprogramed human liver cells into glucose-responsive, fully functional, insulin producing cells. For more information, visit the company's website at www.orgenesis.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

Continue Reading

FridayJun 16, 2017 10:00 am

RespireRx Pharmaceuticals, Inc. (RSPI) Starts Presentation at the 2017 Marcum Microcap Conference

RespireRx Pharmaceuticals (OTC: RSPI) is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served.  RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable.  The company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress. The company owns patents and patent applications, and holds exclusive licenses, for certain families of chemical compounds that claim the chemical structures and their use in the treatment of these and other disorders.  For more information, visit the company's website at www.respirerx.com About NetworkNewsWire NetworkNewsWire (NNW) is an information…

Continue Reading

FridayJun 16, 2017 9:30 am

AEterna Zentaris, Inc. (NASDAQ: AEZS) Starts Presentation at the 2017 Marcum Microcap Conference

AEterna Zentaris (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies. The company recently completed phase 3 studies of two internally developed compounds and intends to license out certain commercial rights of internally developed products to licensees in non-U.S. territories where such out-licensing would enable the company to ensure development, registration and launch of its product candidates. For more information, visit the company's website at www.aezsinc.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3)…

Continue Reading

ThursdayJun 15, 2017 4:30 pm

Genoil Inc. (GNOLF) Starts Presentation at the 2017 Marcum Microcap Conference

Genoil (OTC: GNOLF) is a clean technology engineering company for the petroleum industries. Genoil has developed its proprietary technology, the Hydroconversion Upgrader (GHU), which converts heavy crude oils and refinery bottoms into clean burning fuels for transportation industries including shipping. The GHU can be placed in remote locations, including receiving terminals, pipelines and ports. The company operates one of the largest and most advanced pilot & design test facilities in the world, from its 147-acre site in Alberta, Canada. For more information, visit the company's website at www.genoil.ca About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users…

Continue Reading

ThursdayJun 15, 2017 4:30 pm

PotNetwork Holdings, Inc. (POTN) Starts Presentation at the 2017 Marcum Microcap Conference

PotNetwork Holdings (OTC: POTN) acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc. Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. For more information, visit the company's website at www.potnetworkholding.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3) a full array of social communication solutions. As a multifaceted financial news and content distribution company…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000